Baxter Gets FDA Warning Letter Over Mold, Hair
Baxter Healthcare Corp. failed to investigate extensive mold near a pharmaceutical fill line and produced drug products tainted with hair, skin and other particles, the U.S. Food and Drug Administration said...To view the full article, register now.
Already a subscriber? Click here to view full article